Publicaciones en colaboración con investigadores/as de Hospital Vall d'Hebron (522)

2024

  1. Consensus statement of the Spanish Society of Neurology on the treatment of multiple sclerosis and holistic patient management in 2023

    Neurologia, Vol. 39, Núm. 2, pp. 196-208

  2. Diagnosis and treatment of myocarditis and inflammatory cardiomyopathy. Consensus document of the SEC-Working Group on Myocarditis

    Revista Espanola de Cardiologia

  3. Feasibility and outcomes after dose reduction of immunochemotherapy in young adults with Burkitt lymphoma and leukemia: results of the BURKIMAB14 trial

    Haematologica, Vol. 109, Núm. 2, pp. 543-552

  4. Long-term survival after cardiac arrest in patients undergoing emergent coronary angiography

    Cardiovascular Revascularization Medicine, Vol. 60, pp. 18-26

  5. Plasma fibrinogen and risk of vascular recurrence after ischaemic stroke: An individual participant and summary-level data meta-analysis of 11 prospective studies

    European Stroke Journal

  6. Real-world adalimumab survival and discontinuation factors in hidradenitis suppurativa

    Journal of the European Academy of Dermatology and Venereology

  7. RhoA downregulation in the murine intestinal epithelium results in chronic Wnt activation and increased tumorigenesis

    iScience, Vol. 27, Núm. 4

  8. Surrogate endpoints in phase III randomized trials of advanced gastroesophageal cancer: A systematic review and meta-analysis

    Critical Reviews in Oncology/Hematology, Vol. 201

  9. Therapeutic outcomes and survival analysis of Extramammary Paget's disease: A multicentre retrospective study of 249 patients

    Journal of the American Academy of Dermatology, Vol. 90, Núm. 1, pp. 66-73

  10. Use of social media in radiation oncology: multicenter data from the GOCO Group

    Reports of Practical Oncology and Radiotherapy, Vol. 29, Núm. 2, pp. 236-244

2023

  1. An Integral Approach to the Molecular Diagnosis of Tuberous Sclerosis Complex: The Role of Mosaicism and Splicing Variants

    Journal of Molecular Diagnostics, Vol. 25, Núm. 9, pp. 692-701

  2. Assessment of dyspneic sensation in patients with type 2 diabetes

    Frontiers in Endocrinology, Vol. 14

  3. Corrigendum to “Differences between childhood- and adulthood-onset eosinophilic esophagitis: An analysis from the EoE connect registry” [Digestive and Liver Disease Volume 55, Issue 3, March 2023, Pages 350–359] (Digestive and Liver Disease (2023) 55(3) (350–359), (S1590865822007289), (10.1016/j.dld.2022.09.020))

    Digestive and Liver Disease

  4. Data analysis from the Spanish Registry of Cardiac Surgery (RECC) 2021-2022

    Cirugia Cardiovascular, Vol. 30, Núm. 6, pp. 335-347

  5. Data quality validation of the Spanish Incisional Hernia Surgery Registry (EVEREG): pilot study

    Hernia, Vol. 27, Núm. 3, pp. 665-670

  6. Delivery Systems in Ocular Retinopathies: The Promising Future of Intravitreal Hydrogels as Sustained-Release Scaffolds

    Pharmaceutics, Vol. 15, Núm. 5

  7. Development of a Guide to Multidimensional Needs Assessment in the Palliative Care Initial Encounter (MAP)

    Journal of Pain and Symptom Management, Vol. 66, Núm. 4, pp. 361-369.e6

  8. Differences between childhood- and adulthood-onset eosinophilic esophagitis: An analysis from the EoE connect registry

    Digestive and Liver Disease, Vol. 55, Núm. 3, pp. 350-359

  9. Effectiveness of fosfomycin trometamol as oral step-down therapy for bacteraemic urinary tract infections due to MDR Escherichia coli: a post hoc analysis of the FOREST randomized trial

    The Journal of antimicrobial chemotherapy, Vol. 78, Núm. 7, pp. 1658-1666

  10. Epidemiology of GII.4 and GII.2 norovirus outbreaks in closed and semi-closed institutions in 2017 and 2018

    Scientific Reports, Vol. 13, Núm. 1